Position in TLRY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$133,545
-$48,687 QoQ
Shares Held
20,641
+2.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Derivatives in TLRY
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$776
PutShares
120
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $195,360,884 across 29 Drug Manufacturers - Specialty & Generic names. TLRY ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
615,099 | $72,710,847 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
879,345 | $26,485,869 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
1,098,996 | $22,815,153 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
230,072 | $17,692,535 | |
| 5 | VTRS |
Viatris Inc
|
1,247,615 | $16,855,274 | |
| 6 | HLN |
Haleon plc
|
946,633 | $9,475,792 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
13,915 | $8,251,314 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
929,431 | $5,018,926 |
All Filings in TLRY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $776 | 120 | Put | Defined | 2026-05-13 | |
| 2026-03-31 | $133,545 | 20,641 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $182,232 | 20,181 | Shares | Defined | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||